Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1953 2
1954 1
1955 2
1956 2
1958 1
1964 1
1966 2
1967 1
1968 2
1969 2
1970 1
1971 5
1972 6
1973 10
1974 3
1975 4
1976 4
1977 2
1978 3
1979 2
1980 1
1981 4
1982 2
1983 7
1984 1
1985 2
1986 3
1987 1
1988 1
1989 3
1991 3
1992 1
1993 1
1995 2
1996 4
1997 2
1998 1
1999 1
2000 2
2002 1
2003 1
2005 2
2006 4
2007 4
2008 5
2010 1
2011 3
2012 4
2013 11
2014 10
2015 8
2016 14
2017 14
2018 8
2019 12
2020 17
2021 11
2022 8
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Results by year

Filters applied: . Clear all
Page 1
Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.
Nutting C, Finneran L, Roe J, Sydenham MA, Beasley M, Bhide S, Boon C, Cook A, De Winton E, Emson M, Foran B, Frogley R, Petkar I, Pettit L, Rooney K, Roques T, Srinivasan D, Tyler J, Hall E; DARS Trialist Group. Nutting C, et al. Lancet Oncol. 2023 Aug;24(8):868-880. doi: 10.1016/S1470-2045(23)00265-6. Epub 2023 Jul 6. Lancet Oncol. 2023. PMID: 37423227 Free article. Clinical Trial.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, Ritchie AW, Parker CC, Russell JM, Attard G, de Bono J, Cross W, Jones RJ, Thalmann G, Amos C, Matheson D, Millman R, Alzouebi M, Beesley S, Birtle AJ, Brock S, Cathomas R, Chakraborti P, Chowdhury S, Cook A, Elliott T, Gale J, Gibbs S, Graham JD, Hetherington J, Hughes R, Laing R, McKinna F, McLaren DB, O'Sullivan JM, Parikh O, Peedell C, Protheroe A, Robinson AJ, Srihari N, Srinivasan R, Staffurth J, Sundar S, Tolan S, Tsang D, Wagstaff J, Parmar MK; STAMPEDE investigators. James ND, et al. Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21. Lancet. 2016. PMID: 26719232 Free PMC article. Clinical Trial.
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.
Fennell DA, Ewings S, Ottensmeier C, Califano R, Hanna GG, Hill K, Danson S, Steele N, Nye M, Johnson L, Lord J, Middleton C, Szlosarek P, Chan S, Gaba A, Darlison L, Wells-Jordan P, Richards C, Poile C, Lester JF, Griffiths G; CONFIRM trial investigators. Fennell DA, et al. Lancet Oncol. 2021 Nov;22(11):1530-1540. doi: 10.1016/S1470-2045(21)00471-X. Epub 2021 Oct 14. Lancet Oncol. 2021. PMID: 34656227 Free PMC article. Clinical Trial.
Chronic pain and health inequalities: why we need to act.
Macgregor C, Blane DN, Pravinkumar SJ, Booth G. Macgregor C, et al. Scand J Pain. 2022 Dec 21;23(2):225-227. doi: 10.1515/sjpain-2022-0148. Print 2023 Apr 25. Scand J Pain. 2022. PMID: 36538024 Free article. No abstract available.
A review of posterior chamber phakic intraocular lenses.
Reinstein DZ, MacGregor C, Archer TJ, Gupta R, Potter JG. Reinstein DZ, et al. Among authors: macgregor c. Curr Opin Ophthalmol. 2024 Mar 1;35(2):138-146. doi: 10.1097/ICU.0000000000001018. Epub 2023 Dec 6. Curr Opin Ophthalmol. 2024. PMID: 38059758 Review.
A review of keratoconus: Diagnosis, pathophysiology, and genetics.
Mas Tur V, MacGregor C, Jayaswal R, O'Brart D, Maycock N. Mas Tur V, et al. Among authors: macgregor c. Surv Ophthalmol. 2017 Nov-Dec;62(6):770-783. doi: 10.1016/j.survophthal.2017.06.009. Epub 2017 Jul 6. Surv Ophthalmol. 2017. PMID: 28688894 Review.
[Puerperium].
MacGregor C, Zárate-Treviño A, Canales ES, Soria J. MacGregor C, et al. Gac Med Mex. 1975 Sep;110(3):160-2. Gac Med Mex. 1975. PMID: 1205057 Spanish. No abstract available.
224 results